{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:55:39Z","timestamp":1789728939594,"version":"4.0.1"},"reference-count":183,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbalip.2021.159058","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T07:46:27Z","timestamp":1633506387000},"page":"159058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["High-density lipoproteins (HDL): Novel function and therapeutic applications"],"prefix":"10.1016","volume":"1867","author":[{"given":"Maryam","family":"Darabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatol","family":"Kontush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2021.159058_bb0005","series-title":"Therapeutic Lipidology","author":"Davidson","year":"2021"},{"key":"10.1016\/j.bbalip.2021.159058_bb0010","series-title":"High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics","author":"Kontush","year":"2012"},{"key":"10.1016\/j.bbalip.2021.159058_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","article-title":"Structure of HDL: particle subclasses and molecular components","volume":"224","author":"Kontush","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0020","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.metabol.2011.12.002","article-title":"A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease","volume":"61","author":"Kei","year":"2012","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbalip.2021.159058_bb0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbalip.2021.159058_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","article-title":"Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors","volume":"31","author":"Chapman","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159058_bb0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0040","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0045","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbalip.2019.01.005","article-title":"Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties","volume":"1864","author":"Sukhorukov","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbalip.2021.159058_bb0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0060","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/ncomms4292","article-title":"HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells","volume":"5","author":"Tabet","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2021.159058_bb0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1373\/clinchem.2010.155333","article-title":"HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events","volume":"57","author":"Rosenson","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0070","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2016.08.038","article-title":"High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: the CANHEART study","volume":"68","author":"Ko","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0075","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159058_bb0080","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacl.2018.01.014","article-title":"Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: the EPOCH-JAPAN study","volume":"12","author":"Hirata","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0085","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehx665","article-title":"U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies","volume":"39","author":"Madsen","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159058_bb0090","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1373\/clinchem.2018.299636","article-title":"Low HDL cholesterol and high risk of autoimmune disease: two population-based cohort studies including 117,341 individuals","volume":"65","author":"Madsen","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0095","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/ATVBAHA.117.310587","article-title":"High-density lipoprotein cholesterol and mortality: too much of a good thing?","volume":"38","author":"Hamer","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2019.01.035","article-title":"Very high high-density lipoprotein cholesterol is associated with increased all-cause mortality in South Koreans","volume":"283","author":"Oh","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0105","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1093\/eurheartj\/eht343","article-title":"High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality","volume":"34","author":"Silbernagel","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159058_bb0110","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.116.307024","article-title":"The high-density lipoprotein puzzle: why classic epidemiology, genetic epidemiology, and clinical trials conflict?","volume":"36","author":"Rosenson","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbalip.2014.07.015","article-title":"HDL and atherosclerosis: insights from inherited HDL disorders","volume":"1851","author":"Calabresi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2021.159058_bb0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrendo.2012.238","article-title":"HDL\u2013is it too big to fail?","volume":"9","author":"Ng","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0125","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/CIRCULATIONAHA.118.034706","article-title":"Complete and partial lecithin:cholesterol acyltransferase deficiency is differentially associated with atherosclerosis","volume":"138","author":"Oldoni","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159058_bb0130","doi-asserted-by":"crossref","first-page":"34508","DOI":"10.1074\/jbc.M006738200","article-title":"ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages","volume":"275","author":"Oram","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0135","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2021.159058_bb0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","article-title":"Genetic variant of the scavenger receptor BI in humans","volume":"364","author":"Vergeer","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0145","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/eurheartj\/ehy169","article-title":"Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease","volume":"39","author":"Helgadottir","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159058_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOL.0000000000000332","article-title":"Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation","volume":"27","author":"Yamashita","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0155","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.jacc.2012.07.045","article-title":"Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects","volume":"60","author":"Johannsen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0160","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2021.159058_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.117.311978","article-title":"Trials and tribulations of CETP inhibitors","volume":"122","author":"Tall","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2017.78","article-title":"Mendelian randomization in cardiometabolic disease: challenges in evaluating causality","volume":"14","author":"Holmes","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease","volume":"1","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2021.159058_bb0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithins:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0185","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.2937","article-title":"The not-so-simple HDL story: is it time to revise the HDL cholesterol hypothesis?","volume":"18","author":"Rader","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-015-0554-1","article-title":"HDL cholesterol efflux capacity: cardiovascular risk factor and potential therapeutic target","volume":"18","author":"Bhatt","year":"2016","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.bbalip.2021.159058_bb0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbalip.2021.159058_bb0200","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MOL.0000000000000294","article-title":"HDLs in crises","volume":"27","author":"von Eckardstein","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000315109","article-title":"Endothelial functions of sphingosine-1-phosphate","volume":"26","author":"Lucke","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0210","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease","volume":"45","author":"Do","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2021.159058_bb0215","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/ATVBAHA.118.310727","article-title":"Is it time for new thinking about high-density lipoprotein?","volume":"38","author":"Madsen","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/MOL.0b013e32832afd63","article-title":"Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins","volume":"20","author":"von Eckardstein","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0225","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.001826","article-title":"Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion","volume":"1","author":"Turner","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbalip.2021.159058_bb0230","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI200112810","article-title":"Monocyte\/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels","volume":"108","author":"Haghpassand","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2014.02.032","article-title":"Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia","volume":"234","author":"El Khoury","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0240","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1172\/JCI27602","article-title":"HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway","volume":"116","author":"Matsuura","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0245","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","article-title":"Inflammatory\/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment","volume":"108","author":"Ansell","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159058_bb0250","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1161\/ATVBAHA.112.248617","article-title":"Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways","volume":"32","author":"Huang","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0255","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.ph.45.030183.003205","article-title":"Intestinal synthesis, secretion, and transport of lipoproteins","volume":"45","author":"Bisgaier","year":"1983","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0260","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCULATIONAHA.118.035358","article-title":"Is low-density lipoprotein cholesterol the key to interpret the role of lecithin:cholesterol acyltransferase in atherosclerosis?","volume":"138","author":"Vitali","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159058_bb0265","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1194\/jlr.M300511-JLR200","article-title":"Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans","volume":"45","author":"Schwartz","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0270","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/ATVBAHA.108.179283","article-title":"Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0275","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2017.01.034","article-title":"SR-BI as target in atherosclerosis and cardiovascular disease - a comprehensive appraisal of the cellular functions of SR-BI in physiology and disease","volume":"258","author":"Hoekstra","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0280","first-page":"5936","article-title":"Biliary cholesterol secretion: more than a simple ABC","volume":"16","author":"Dikkers","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0285","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0290","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0295","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0300","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"H.T.R.C. Group","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0305","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/FJC.0b013e3181cf03cb","article-title":"Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibition","volume":"55","author":"Connelly","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.plipres.2014.07.003","article-title":"Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology","volume":"56","author":"Birner-Gruenberger","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0315","series-title":"Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion, Arterioscler Thromb Vasc Biol","first-page":"1057","volume":"vol. 25","author":"Brousseau","year":"2005"},{"key":"10.1016\/j.bbalip.2021.159058_bb0320","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI116314","article-title":"Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate","volume":"91","author":"Schwartz","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0325","first-page":"325","article-title":"High-density lipoproteins: biology, epidemiology, and clinical management","volume":"33","author":"Choi","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0330","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pathol.2018.10.017","article-title":"HDL and cardiovascular disease","volume":"51","author":"Nicholls","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.bbalip.2021.159058_bb0335","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"H.T.C. Group","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0340","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jacc.2013.07.023","article-title":"Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL\/High Triglycerides and Impact on Global Health Outcomes)","volume":"62","author":"Guyton","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0345","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2021.159058_bb0350","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/eurheartj\/ehu171","article-title":"Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial","volume":"35","author":"Tardif","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159058_bb0355","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamacardio.2018.2121","volume":"3","author":"Nicholls","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0360","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/1381612822666161027153140","article-title":"HDL-targeting therapeutics: past, present and future","volume":"23","author":"Zakiev","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbalip.2021.159058_bb0365","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/clpt.2014.79","article-title":"High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm","volume":"96","author":"Tuteja","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbalip.2021.159058_bb0370","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.106.138347","article-title":"Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL","volume":"27","author":"Yvan-Charvet","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0375","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/ATVBAHA.110.207142","article-title":"Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0380","doi-asserted-by":"crossref","first-page":"g4379","DOI":"10.1136\/bmj.g4379","article-title":"Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients","volume":"349","author":"Keene","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.bbalip.2021.159058_bb0385","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2015.03.089","article-title":"Innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C\/LDL-C-lowering versus HDL-C-raising: a systematic review and meta-analysis of relevant preclinical studies and clinical trials","volume":"763","author":"Kuhnast","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0390","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/ATVBAHA.115.306138","article-title":"Novel pathways of apolipoprotein A-I metabolism in high-density lipoprotein of different sizes in humans","volume":"36","author":"Mendivil","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0395","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1161\/ATVBAHA.117.310290","article-title":"ABCA1-derived nascent high-density lipoprotein\u2013apolipoprotein AI and lipids metabolically segregate","volume":"37","author":"Xu","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0400","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacl.2018.04.001","article-title":"Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins","volume":"12","author":"Gillard","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14797\/mdcj-15-1-47","article-title":"Revisiting reverse cholesterol transport in the context of high-density lipoprotein free cholesterol bioavailability","volume":"15","author":"Rosales","year":"2019","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"10.1016\/j.bbalip.2021.159058_bb0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2018.08.032","article-title":"Direct observation of cargo transfer from HDL particles to the plasma membrane","volume":"277","author":"Plochberger","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0415","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/ATVBAHA.117.307025","article-title":"From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease","volume":"38","author":"Sacks","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0420","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2021.159058_bb0425","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","article-title":"Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease","volume":"64","author":"Rosenson","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0430","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-8703(87)90629-6","article-title":"Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism","volume":"113","author":"Nikkila","year":"1987","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbalip.2021.159058_bb0435","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2362.1982.tb00947.x","article-title":"Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity","volume":"12","author":"Magill","year":"1982","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbalip.2021.159058_bb0440","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2019.05.011","article-title":"A third of nonfasting plasma cholesterol is in remnant lipoproteins: lipoprotein subclass profiling in 9293 individuals","volume":"286","author":"Balling","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0445","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0450","doi-asserted-by":"crossref","first-page":"dgz265","DOI":"10.1210\/clinem\/dgz265","article-title":"Low high-density lipoprotein cholesterol to monitor long-term average increased triglycerides","volume":"105","author":"Langsted","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2021.159058_bb0455","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/CIRCOUTCOMES.115.002436","article-title":"Is isolated low high-density lipoprotein cholesterol a cardiovascular disease risk factor? New insights from the Framingham Offspring Study","volume":"9","author":"Bartlett","year":"2016","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.bbalip.2021.159058_bb0460","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/ATVBAHA.114.305172","article-title":"Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human genetics","volume":"35","author":"Khetarpal","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0465","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.ATV.14.4.622","article-title":"Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins","volume":"14","author":"Chung","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.bbalip.2021.159058_bb0470","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI114024","article-title":"Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?","volume":"83","author":"Chung","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0475","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0480","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jacl.2019.04.043","article-title":"Meta-analysis of effects of triglyceride modifiers on cardiovascular outcomes","volume":"13","author":"Rahman","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0485","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.75.9.4519","article-title":"Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro","volume":"75","author":"Patsch","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2021.159058_bb0490","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0022-2275(20)38031-7","article-title":"Transfer of human lymph chylomicron constituents to other lipoprotein density fractions during in vitro lipolysis","volume":"23","author":"Schaefer","year":"1982","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0495","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0005-2760(96)00105-1","article-title":"Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL","volume":"1303","author":"Murdoch","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2021.159058_bb0500","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJM197811302992207","article-title":"Plasma high-density lipoproteins","volume":"299","author":"Tall","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0505","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-2275(20)32063-0","article-title":"Lipolytic remnants of human VLDL produced in vitro. Effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants","volume":"41","author":"Chung","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0510","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0022-2275(20)37308-9","article-title":"Intestinal lipoprotein metabolism","volume":"22","author":"Green","year":"1981","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0515","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0021-9150(82)90109-5","article-title":"In vitro reciprocal exchange of apoproteins and nonpolar lipids between human high density lipoproteins and an artificial triglyceride-phospholipid emulsion (intralipid)","volume":"44","author":"Weinberg","year":"1982","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0520","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2362.1983.tb00123.x","article-title":"Free cholesterol distribution during in vitro lipolysis of rat plasma very low density lipoprotein: lack of a role for blood and heart cells","volume":"13","author":"Perret","year":"1983","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbalip.2021.159058_bb0525","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ajcn\/36.2.235","article-title":"Cholesterol turnover in human plasma lipoproteins: studies with stable and radioactive isotopes","volume":"36","author":"Ferezou","year":"1982","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbalip.2021.159058_bb0530","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.RES.86.7.768","article-title":"Direct visualization of lipid deposition and reverse lipid transport in a perfused artery - roles of VLDL and HDL","volume":"86","author":"Rutledge","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0535","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1172\/JCI109086","article-title":"Very low density lipoprotein. Metabolism of phospholipids, cholesterol, and apolipoprotein C in the isolated perfused rat heart","volume":"61","author":"Chajek","year":"1978","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0540","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1172\/JCI109564","article-title":"Metabolic fate of chylomicron phospholipids and apoproteins in the rat","volume":"64","author":"Tall","year":"1979","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0545","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0021-9150(82)90202-7","article-title":"In vitro catabolism of human plasma very low density lipoproteins. Effects of VLDL concentration on the interconversion of high density lipoprotein subfractions","volume":"41","author":"Taskinen","year":"1982","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0550","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1139\/o85-110","article-title":"The catabolism of very low density lipoproteins","volume":"63","author":"Breckenridge","year":"1985","journal-title":"Can. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0555","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(95)05606-8","article-title":"Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL","volume":"118","author":"Murdoch","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0560","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1172\/JCI114732","article-title":"Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys","volume":"86","author":"Goldberg","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0565","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0021-9150(78)90178-8","article-title":"Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man","volume":"29","author":"Nikkila","year":"1978","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0570","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1177\/2047487319894114","article-title":"Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease","volume":"27","author":"Feng","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0575","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0022-2275(20)38540-0","article-title":"Interactions of high density lipoproteins with very low and low density lipoproteins during lipolysis","volume":"29","author":"Musliner","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0580","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.ATV.3.6.607","article-title":"Changes of high density lipoprotein subfraction concentration and composition by intralipid in vivo and by lipolysis of intralipid in vitro","volume":"3","author":"Taskinen","year":"1983","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0585","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0021-9258(19)68346-8","article-title":"Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat","volume":"257","author":"Tall","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0590","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-2275(20)37757-9","article-title":"Effects of fat ingestion on high density lipoprotein profiles in human sera","volume":"25","author":"Groot","year":"1984","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0595","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI113078","article-title":"High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase","volume":"80","author":"Patsch","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0600","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0021-9150(80)90012-X","article-title":"Relationship between triglyceride-rich lipoprotein (chylomicrons and VLDL) and HDL2 and HDL3 in the post-prandial phase in humans","volume":"37","author":"Baggio","year":"1980","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2008.11.146","article-title":"Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein","volume":"379","author":"Miyazaki","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2021.159058_bb0610","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/265163a0","article-title":"Solubilisation of phospholipid membranes by human plasma high density lipoproteins","volume":"265","author":"Tall","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2021.159058_bb0615","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nsmb.2028","article-title":"Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma","volume":"18","author":"Huang","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0620","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2012.06.023","article-title":"What does HDL do? A new mechanism to slow atherogenesis\u2013but a new problem in type 2 diabetes mellitus","volume":"225","author":"Williams","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0625","first-page":"491","article-title":"Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease","volume":"3","author":"Olofsson","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.bbalip.2021.159058_bb0630","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0022-2275(20)35361-X","article-title":"Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods","volume":"34","author":"Ikewaki","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0635","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1016\/S0021-9258(18)50321-5","article-title":"Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat","volume":"254","author":"Wu","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0640","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/S0021-9258(19)69716-4","article-title":"Biosynthesis of plasma apolipoproteins by rat small intestine without dietary or biliary fat","volume":"256","author":"Windmueller","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0645","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1172\/JCI110103","article-title":"Transport of apolipoproteins A-I and A-II by human thoracic duct lymph","volume":"67","author":"Anderson","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0650","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000070395","article-title":"Low-density lipoprotein receptor and apolipoprotein A-I and B expression in human enterocytes","volume":"67","author":"Sviridov","year":"2003","journal-title":"Digestion"},{"key":"10.1016\/j.bbalip.2021.159058_bb0655","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/S0022-2275(20)35345-1","article-title":"Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters","volume":"34","author":"Cohn","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0660","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0163-7827(95)00005-K","article-title":"Intestinal lipoprotein synthesis and secretion","volume":"34","author":"Field","year":"1995","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0665","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0022-2275(20)41271-4","article-title":"Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins","volume":"19","author":"Imaizumi","year":"1978","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0670","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1172\/JCI109444","article-title":"Human intestinal lipoproteins. Studies in chyluric subjects","volume":"64","author":"Green","year":"1979","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0675","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1388-1981(03)00058-1","article-title":"Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions","volume":"1632","author":"Yamamoto","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2021.159058_bb0680","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-2275(20)41989-3","article-title":"Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I","volume":"32","author":"Musliner","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0685","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1016\/S0021-9258(17)42741-4","article-title":"Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins","volume":"259","author":"Tall","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0690","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2006.06.030","article-title":"Partial suppression of CETP activity beneficially modifies the lipid transfer profile of plasma","volume":"192","author":"Morton","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0695","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1194\/jlr.R027011","article-title":"New molecular insights into CETP structure and function: a review","volume":"53","author":"Charles","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2091-2-1","article-title":"Plasma lipases and lipid transfer proteins increase phospholipid but not free cholesterol transfer from lipid emulsion to high density lipoproteins","volume":"2","author":"Nunes","year":"2001","journal-title":"BMC Biochem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0705","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(98)00169-5","article-title":"In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase","volume":"141","author":"Chung","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.03.002","article-title":"Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk","volume":"324","author":"Ma","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0715","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1194\/jlr.M031336","article-title":"Serum albumin acts as a shuttle to enhance cholesterol efflux from cells","volume":"54","author":"Sankaranarayanan","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0720","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI111624","article-title":"Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase","volume":"74","author":"Patsch","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0725","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1038\/ncomms15010","article-title":"Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport","volume":"8","author":"Bartelt","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2021.159058_bb0730","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00041433-200406000-00008","article-title":"Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids","volume":"15","author":"Connelly","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0735","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.106.2748.190","article-title":"Atherosclerosis and alimentary Hyperlipemia","volume":"106","author":"Moreton","year":"1947","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2021.159058_bb0740","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.107.2780.371","article-title":"Physical state of lipids and foreign substances producing atherosclerosis","volume":"107","author":"Moreton","year":"1948","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2021.159058_bb0745","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a postprandial phenomenon","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159058_bb0750","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Boren","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0755","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11886-016-0745-6","article-title":"Triglyceride-rich lipoproteins and remnants: targets for therapy?","volume":"18","author":"Dallinga-Thie","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.bbalip.2021.159058_bb0760","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11745-008-3165-6","article-title":"Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction","volume":"43","author":"Lekhal","year":"2008","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2021.159058_bb0765","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.molmed.2020.07.005","article-title":"HDL and reverse remnant-cholesterol transport (RRT): relevance to cardiovascular disease","volume":"26","author":"Kontush","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0770","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1073\/pnas.80.5.1449","article-title":"Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia","volume":"80","author":"Patsch","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2021.159058_bb0775","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0021-9150(97)00287-6","article-title":"Delayed increase in high density lipoprotein-phospholipids after ingestion of a fat load in normolipidemic patients with coronary artery disease","volume":"137","author":"Groener","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800141-7.00001-2","article-title":"HDL metabolism and atheroprotection: predictive value of lipid transfers","volume":"65","author":"Maranhao","year":"2014","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0785","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2362.2004.01360.x","article-title":"HDL metabolic activities in a boy with lipoprotein lipase deficiency and his family","volume":"34","author":"Brites","year":"2004","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbalip.2021.159058_bb0790","series-title":"George Lyman Duff Memorial Lecture, Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease","first-page":"700","volume":"38","author":"Goldberg","year":"2017-2018"},{"key":"10.1016\/j.bbalip.2021.159058_bb0795","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-2275(20)34958-0","article-title":"Plasma lipoprotein changes resulting from immunologically blocked lipolysis","volume":"22","author":"Behr","year":"1981","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0800","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1161\/01.ATV.15.12.2157","article-title":"Apolipoprotein A-I deficiency. Biochemical and metabolic characteristics","volume":"15","author":"Ng","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0805","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1172\/JCI114997","article-title":"A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities","volume":"87","author":"Funke","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0810","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-2275(20)33893-1","article-title":"ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice","volume":"39","author":"Voyiaziakis","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0815","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jcp.56.12.937","article-title":"Postprandial hypertriglyceridaemia in patients with Tangier disease","volume":"56","author":"Kolovou","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0820","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0005-2760(87)90305-5","article-title":"Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes","volume":"920","author":"Wang","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2021.159058_bb0825","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.1074\/jbc.M109.096933","article-title":"Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism","volume":"285","author":"Chung","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0830","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150083","article-title":"Lipoprotein X causes renal disease in LCAT deficiency","volume":"11","author":"Ossoli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2021.159058_bb0835","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0022-2275(20)37885-8","article-title":"Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart","volume":"24","author":"Tam","year":"1983","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0840","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0021-9150(82)90050-8","article-title":"A unified model of esterified cholesterol exchanges between human plasma lipoproteins","volume":"44","author":"Barter","year":"1982","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159058_bb0845","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.ATV.0000118276.87061.00","article-title":"Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties","volume":"24","author":"Kontush","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0850","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1194\/jlr.M300198-JLR200","article-title":"Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency","volume":"45","author":"Asztalos","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0855","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","article-title":"High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies","volume":"51","author":"van der Steeg","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0860","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1172\/JCI111786","article-title":"Effects of postprandial lipemia on plasma cholesterol metabolism","volume":"75","author":"Castro","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159058_bb0865","doi-asserted-by":"crossref","first-page":"23150","DOI":"10.1074\/jbc.M113.495523","article-title":"Mechanisms responsible for the compositional heterogeneity of nascent high density lipoprotein","volume":"288","author":"Lund-Katz","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0870","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0009-3084(01)00186-4","article-title":"Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles","volume":"113","author":"Sigalov","year":"2001","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbalip.2021.159058_bb0875","doi-asserted-by":"crossref","first-page":"40859","DOI":"10.1074\/jbc.M306580200","article-title":"Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP)","volume":"278","author":"Paromov","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2021.159058_bb0880","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2021.159058_bb0885","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0890","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.4390","article-title":"A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels","volume":"23","author":"Khetarpal","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2021.159058_bb0895","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cvr\/cvu147","article-title":"HDL-mediated mechanisms of protection in cardiovascular disease","volume":"103","author":"Kontush","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2021.159058_bb0900","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","article-title":"Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis","volume":"297","author":"Nicholls","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2021.159058_bb0905","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.metabol.2008.02.014","article-title":"Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells","volume":"57","author":"Qin","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2021.159058_bb0910","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/ATVBAHA.109.194555","article-title":"HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis","volume":"29","author":"Zerrad-Saadi","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159058_bb0915","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3390\/ijms20102521","article-title":"Atorvastatin and fenofibrate increase the content of unsaturated acyl chains in HDL and modify in vivo kinetics of HDL-cholesteryl esters in New Zealand White Rabbits","volume":"20","author":"Flores-Castillo","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198121001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198121001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:11:18Z","timestamp":1761387078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198121001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":183,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1388198121001864"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2021.159058","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoproteins (HDL): Novel function and therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2021.159058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"159058"}}